their RWD and continuous improvement model bringing 'agile' into the drug development process. should really boost their learnings. this trial is arguably got backing of 10,000 additional patents across like 150 indications.
1+1 learning to feed into the trial.
data that is captured correctly and ethically.
their RWD and continuous improvement model bringing...
-
- There are more pages in this discussion • 252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(3.26%) |
Mkt cap ! $18.20M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.5¢ | $21.39K | 460.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 269585 | 1 |
View Market Depth
| Last trade - 15.33pm 06/09/2024 (20 minute delay) ? |
| EMD (ASX) Chart |